Patents by Inventor Erick M. Roane

Erick M. Roane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11998752
    Abstract: A wearable cardioverter defibrillator (WCD) system comprises a plurality of patient parameter electrodes and a plurality of defibrillator electrodes to contact a patient's skin when the WCD is delivering therapy to the patient, a processor to receive one or more patient parameters from the one or more patient parameter electrodes, an energy storage device to store a charge to provide electrical therapy to the patient via the plurality of defibrillator electrodes, and a non-invasive blood pressure (NIBP) monitor to obtain a blood pressure measurement of the patient and to provide the blood pressure measurement to the processor. The processor is to determine whether to provide electrical therapy to the patient based on the one or more patient parameters during an episode, and to obtain the blood pressure measurement from the NIBP monitor during the episode.
    Type: Grant
    Filed: April 13, 2022
    Date of Patent: June 4, 2024
    Assignee: West Affum Holdings DAC
    Inventors: Kenneth F. Cowan, Steven E. Sjoquist, Zoie R. Engman, Erick M. Roane, Laura M. Gustavson, Douglas K. Medema, Garrett M. Kotlarchik, Pamela Breske, Jonathan P. Niegowski, Joseph L. Sullivan, Robert R. Buchanan
  • Publication number: 20240119380
    Abstract: Embodiments of this disclosure are directed to a wearable cardioverter defibrillator (“WCD”) system design in which a WCD implements an alert prioritization scheme to provide the patient with feedback in an order that is less likely to cause confusion. Different conditions (e.g., device status, equipment condition, or physiologic condition) are prioritized based on an analysis of severity of the condition and timeliness of user action needed. The prioritization scheme defines what alert, if any, is presented to the user by the WCD system as a result of various conditions. Generally stated, an alert for the highest priority condition currently detected is presented to the user and maintained until that condition either changes or becomes surpassed in the prioritization scheme.
    Type: Application
    Filed: December 15, 2023
    Publication date: April 11, 2024
    Applicant: West Affum Holdings DAC
    Inventors: Zoie R. Engman, Pamela F. Breske, David P. Finch, Erick M. Roane
  • Patent number: 11931591
    Abstract: Disclosed are embodiments directed to security methods applied to connections between components in a distributed (networked) system including medical and non-medical devices, providing secure authentication, authorization, patient and device data transfer, and patient data association and privacy for components of the system.
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: March 19, 2024
    Assignee: West Affum Holdings DAC
    Inventors: Steven E. Sjoquist, David P. Finch, Erick M. Roane, Zoie R. Engman, Jonathan P. Niegowski, Dusan Beblavy, Martin Pribula, Peter Curila, Martin Kolesár
  • Patent number: 11880792
    Abstract: Embodiments of this disclosure are directed to a wearable cardioverter defibrillator (“WCD”) system design in which a WCD implements an alert prioritization scheme to provide the patient with feedback in an order that is less likely to cause confusion. Different conditions (e.g., device status, equipment condition, or physiologic condition) are prioritized based on an analysis of severity of the condition and timeliness of user action needed. The prioritization scheme defines what alert, if any, is presented to the user by the WCD system as a result of various conditions. Generally stated, an alert for the highest priority condition currently detected is presented to the user and maintained until that condition either changes or becomes surpassed in the prioritization scheme.
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: January 23, 2024
    Assignee: West Affum Holdings DAC
    Inventors: Zoie R. Engman, Pamela F. Breske, David P. Finch, Erick M. Roane
  • Patent number: 11819704
    Abstract: In one embodiment, a method to alert a user of a wearable cardioverter defibrillator (WCD) is described. The method includes determining when a system issue is resolved and issuing an alert when the system issue is resolved. In some embodiments, the method may detect the system issue and issuing a system alert based at least in part on the system issue. The method may then monitor a status of the system issue. In some instances, the method may detect an abnormality in system operation sand determine a severity rating for the abnormality. The method may determine if the abnormality satisfies a time duration threshold based at least in part on the severity rating.
    Type: Grant
    Filed: February 11, 2021
    Date of Patent: November 21, 2023
    Assignee: WEST AFFUM HOLDINGS DAC
    Inventors: Zoie R. Engman, Pamela F. Breske, Erick M. Roane
  • Publication number: 20230264033
    Abstract: “Artificial Intelligence” or “AI” technology can be applied to Wearable Cardioverter Defibrillators (“WCDs”) and other wearable medical equipment in various ways, including garment fitting and adjustment, analyzing electrocardiogram (“ECG”), other sensor data and/or other patient data in real time to detect/assess the patient's present condition and/or need for treatment for cardiac and other conditions (e.g., stroke, coughing, apnea, etc.), detect imminent failure of the wearable medical device components, capture and report data collected from the patient for presenting to clinicians, adjust thresholds for alarms and notifications based on patient's responses, improve patient compliance based on the patient's past non-compliant behavior and actions that resulted in the patient becoming compliant, provide tests to the patient, and learn the patient's responses to detect/assess the patient's present condition and/or need for treatment.
    Type: Application
    Filed: May 1, 2023
    Publication date: August 24, 2023
    Applicant: West Affum Holdings DAC
    Inventors: Zoie R. Engman, Erick M. Roane, Steven E. Sjoquist, Jonathan P. Niegowski, Robert R. Buchanan
  • Patent number: 11672996
    Abstract: “Artificial Intelligence” or “AI” technology can be applied to Wearable Cardioverter Defibrillators (“WCDs”) and other wearable medical equipment in various ways, including: garment fitting and adjustment; analyzing electrocardiogam (“ECG”), other sensor data and/or other patient data (e.g., age, gender, previous medical conditions, etc.) in real time to detect/assess the patient's present condition and/or need for treatment for cardiac and other conditions (e.g., stroke, coughing, apnea, etc.); detecting imminent failure of the wearable medical device components; capturing and reporting data collected from the patient for presenting to clinicians; adjusting thresholds for alarms and notifications based on patient's responses; improving patient compliance based on the patient's past non-compliant behavior and actions that resulted in the patient becoming compliant; providing tests to the patient (e.g., grip test, dexterity tests, balance tests, etc.
    Type: Grant
    Filed: June 24, 2020
    Date of Patent: June 13, 2023
    Assignee: WEST AFFUM HOLDINGS DAC
    Inventors: Zoie R. Engman, Erick M. Roane, Steven E. Sjoquist, Jonathan P. Niegowski, Robert R. Buchanan
  • Publication number: 20220296909
    Abstract: A wearable cardioverter defibrillator (WCD) comprises a plurality of electrocardiography (ECG) electrodes and a plurality of defibrillator electrodes to contact the patient's skin when the WCD is delivering therapy to the patient, a preamplifier coupled to the ECG electrodes to obtain ECG data from the patient. a processor to receive the ECG data from the preamplifier, and a high voltage subsystem to provide a defibrillation voltage to the patient through the plurality of defibrillator electrodes in response to a shock signal received from the processor. In a first power mode of a range of power modes the preamplifier is configured to perform low-fidelity ECG acquisition and the processor is configured to perform simple arrythmia detection analysis, and in a second mode of the range of power modes the preamplifier is configured to perform high-fidelity ECG acquisition and the processor is configured to perform complex arrythmia detection analysis.
    Type: Application
    Filed: February 28, 2022
    Publication date: September 22, 2022
    Applicant: West Affum Holdings Corp.
    Inventors: David P. Finch, Erick M. Roane, Kenneth F. Cowan, Derek J. Valleroy, Gregory T. Kavounas
  • Publication number: 20220285033
    Abstract: In one embodiment, a WCD is described. The WCD includes a support structure configured to be worn by a patient and a processor coupled to the support structure. The WCD also includes an energy storage module configured to store an electrical charge and in communication with the processor. The WCD also includes a discharge circuit coupled to the energy storage module, the discharge circuit in communication with the processor and configured to discharge the stored electrical charge through a body of the patient. The processor is configured to detect an event at the WCD, classify the detected event, and determine an alarm onset time of the detected event based at least in part on the event classification. The processor is further configured to issue the alarm after the alarm onset time.
    Type: Application
    Filed: May 23, 2022
    Publication date: September 8, 2022
    Applicant: West Affum Holdings Corp.
    Inventors: Zoie R. Engman, David P. Finch, Joseph L. Sullivan, Erick M. Roane, Pamela F. Breske
  • Publication number: 20220266043
    Abstract: Disclosed are embodiments directed to security methods applied to connections between components in a distributed (networked) system including medical and non-medical devices, providing secure authentication, authorization, patient and device data transfer, and patient data association and privacy for components of the system.
    Type: Application
    Filed: May 6, 2022
    Publication date: August 25, 2022
    Applicant: West Affum Holdings Corp.
    Inventors: Steven E. Sjoquist, David P. Finch, Erick M. Roane, Zoie R. Engman, Jonathan P. Niegowski, Dusan Beblavy, Martin Pribula, Peter Curila, Martin Kolesár
  • Publication number: 20220261731
    Abstract: Embodiments of this disclosure are directed to a wearable cardioverter defibrillator (“WCD”) system design in which a WCD implements an alert prioritization scheme to provide the patient with feedback in an order that is less likely to cause confusion. Different conditions (e.g., device status, equipment condition, or physiologic condition) are prioritized based on an analysis of severity of the condition and timeliness of user action needed. The prioritization scheme defines what alert, if any, is presented to the user by the WCD system as a result of various conditions. Generally stated, an alert for the highest priority condition currently detected is presented to the user and maintained until that condition either changes or becomes surpassed in the prioritization scheme.
    Type: Application
    Filed: May 6, 2022
    Publication date: August 18, 2022
    Applicant: West Affum Holdings Corp.
    Inventors: Zoie R. Engman, Pamela F. Breske, David P. Finch, Erick M. Roane
  • Publication number: 20220241601
    Abstract: A wearable cardioverter defibrillator (WCD) system comprises a plurality of patient parameter electrodes and a plurality of defibrillator electrodes to contact a patient's skin when the WCD is delivering therapy to the patient, a processor to receive one or more patient parameters from the one or more patient parameter electrodes, an energy storage device to store a charge to provide electrical therapy to the patient via the plurality of defibrillator electrodes, and a non-invasive blood pressure (NIBP) monitor to obtain a blood pressure measurement of the patient and to provide the blood pressure measurement to the processor. The processor is to determine whether to provide electrical therapy to the patient based on the one or more patient parameters during an episode, and to obtain the blood pressure measurement from the NIBP monitor during the episode.
    Type: Application
    Filed: April 13, 2022
    Publication date: August 4, 2022
    Applicant: West Affum Holdings Corp.
    Inventors: Kenneth F. Cowan, Steven E. Sjoquist, Zoie R. Engman, Erick M. Roane, Laura M. Gustavson, Douglas K. Medema, Garrett M. Kotlarchik, Pamela Breske, Jonathan P. Niegowski, Joseph L. Sullivan, Robert R. Buchanan
  • Publication number: 20220233873
    Abstract: In one embodiment, a wearable cardioverter defibrillator (WCD) is described. The WCD includes a support structure worn by a patient. A processor is coupled to the support structure. The WCD also includes a discharge circuit coupled to an energy storage module, the discharge circuit configured to discharge the stored electrical charge through a body of the patient. The wearable cardioverter defibrillator also includes a user interface housing at least one sensor and responsive to changes in device orientation. The processor is configured to detect a motion at the user interface and determine when the motion is patient-activated. When the motion is patient-activated, the processor determines a direction of rotation. The processor determines an orientation of a display at the user interface based on the direction of rotation and orients the display at the user interface to appear upright to the patient.
    Type: Application
    Filed: April 11, 2022
    Publication date: July 28, 2022
    Applicant: West Affum Holdings Corp.
    Inventors: Zoie R. Engman, Aaron J. Piazza, Erick M. Roane
  • Patent number: 11342079
    Abstract: In one embodiment, a WCD is described. The WCD includes a support structure configured to be worn by a patient and a processor coupled to the support structure. The WCD also includes an energy storage module configured to store an electrical charge and in communication with the processor. The WCD also includes a discharge circuit coupled to the energy storage module, the discharge circuit in communication with the processor and configured to discharge the stored electrical charge through a body of the patient. The processor is configured to detect an event at the WCD, classify the detected event, and determine an alarm onset time of the detected event based at least in part on the event classification. The processor is further configured to issue the alarm after the alarm onset time.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: May 24, 2022
    Assignee: WEST AFFUM HOLDINGS CORP.
    Inventors: Zoie R. Engman, David P. Finch, Joseph L. Sullivan, Erick M. Roane, Pamela F. Breske
  • Patent number: 11331508
    Abstract: A wearable cardioverter defibrillator (WCD) system comprises a plurality of patient parameter electrodes and a plurality of defibrillator electrodes to contact a patient's skin when the WCD is delivering therapy to the patient, a processor to receive one or more patient parameters from the one or more patient parameter electrodes, an energy storage device to store a charge to provide electrical therapy to the patient via the plurality of defibrillator electrodes, and a non-invasive blood pressure (NIBP) monitor to obtain a blood pressure measurement of the patient and to provide the blood pressure measurement to the processor. The processor is to determine whether to provide electrical therapy to the patient based on the one or more patient parameters during an episode, and to obtain the blood pressure measurement from the NIBP monitor during the episode.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: May 17, 2022
    Assignee: West Affum Holdings Corp.
    Inventors: Kenneth F. Cowan, Steven E. Sjoquist, Zoie R. Engman, Erick M. Roane, Laura M. Gustavson, Douglas K. Medema, Garrett M. Kotlarchik, Pamela Breske, Jonathan P. Niegowski, Joseph L. Sullivan, Robert R. Buchanan
  • Patent number: 11334826
    Abstract: Embodiments of this disclosure are directed to a wearable cardioverter defibrillator (“WCD”) system design in which a WCD implements an alert prioritization scheme to provide the patient with feedback in an order that is less likely to cause confusion. Different conditions (e.g., device status, equipment condition, or physiologic condition) are prioritized based on an analysis of severity of the condition and timeliness of user action needed. The prioritization scheme defines what alert, if any, is presented to the user by the WCD system as a result of various conditions. Generally stated, an alert for the highest priority condition currently detected is presented to the user and maintained until that condition either changes or becomes surpassed in the prioritization scheme.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: May 17, 2022
    Assignee: West Affum Holdings Corp.
    Inventors: Zoie R. Engman, Pamela F. Breske, David P. Finch, Erick M. Roane
  • Patent number: 11324960
    Abstract: Disclosed are embodiments directed to security methods applied to connections between components in a distributed (networked) system including medical and non-medical devices, providing secure authentication, authorization, patient and device data transfer, and patient data association and privacy for components of the system.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: May 10, 2022
    Assignee: West Affum Holdings Corp.
    Inventors: Steven E. Sjoquist, David P. Finch, Erick M. Roane, Zoie R. Engman, Jonathan P. Niegowski, Dusan Beblavy, Martin Pribula, Peter Curila, Martin Kolesár
  • Patent number: 11298556
    Abstract: In one embodiment, a wearable cardioverter defibrillator (WCD) is described. The WCD includes a support structure worn by a patient. A processor is coupled to the support structure. The WCD also includes a discharge circuit coupled to an energy storage module, the discharge circuit configured to discharge the stored electrical charge through a body of the patient. The wearable cardioverter defibrillator also includes a user interface housing at least one sensor and responsive to changes in device orientation. The processor is configured to detect a motion at the user interface and determine when the motion is patient-activated. When the motion is patient-activated, the processor determines a direction of rotation. The processor determines an orientation of a display at the user interface based on the direction of rotation and orients the display at the user interface to appear upright to the patient.
    Type: Grant
    Filed: April 25, 2019
    Date of Patent: April 12, 2022
    Assignee: West Affum Holdings Corp.
    Inventors: Zoie R. Engman, Aaron J. Piazza, Erick M. Roane
  • Patent number: 11260238
    Abstract: A wearable cardioverter defibrillator (WCD) comprises a plurality of electrocardiography (ECG) electrodes and a plurality of defibrillator electrodes to contact the patient's skin when the WCD is delivering therapy to the patient, a preamplifier coupled to the ECG electrodes to obtain ECG data from the patient. a processor to receive the ECG data from the preamplifier, and a high voltage subsystem to provide a defibrillation voltage to the patient through the plurality of defibrillator electrodes in response to a shock signal received from the processor. In a first power mode of a range of power modes the preamplifier is configured to perform low-fidelity ECG acquisition and the processor is configured to perform simple arrythmia detection analysis, and in a second mode of the range of power modes the preamplifier is configured to perform high-fidelity ECG acquisition and the processor is configured to perform complex arrythmia detection analysis.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: March 1, 2022
    Assignee: West Affum Holdings Corp.
    Inventors: David P. Finch, Erick M. Roane, Kenneth F. Cowan, Derek J. Valleroy, Gregory T. Kavounas
  • Publication number: 20220054849
    Abstract: In one embodiment, a method to alert a user of a wearable cardioverter defibrillator (WCD) is described. The method includes determining when a system issue is resolved and issuing an alert when the system issue is resolved. In some embodiments, the method may detect the system issue and issuing a system alert based at least in part on the system issue. The method may then monitor a status of the system issue. In some instances, the method may detect an abnormality in system operation sand determine a severity rating for the abnormality. The method may determine if the abnormality satisfies a time duration threshold based at least in part on the severity rating.
    Type: Application
    Filed: February 11, 2021
    Publication date: February 24, 2022
    Applicant: West Affum Holdings Corp.
    Inventors: Zoie R. Engman, Pamela F. Breske, Erick M. Roane